Cymat Technologies Ltd.
CYMHF
$0.09
$0.00-1.62%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.36M | 2.67M | 2.68M | 2.05M | 1.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.36M | 2.67M | 2.68M | 2.05M | 1.88M |
| Cost of Revenue | 1.57M | 2.32M | 2.06M | 1.74M | 1.76M |
| Gross Profit | -212.60K | 358.30K | 620.50K | 300.80K | 120.60K |
| SG&A Expenses | 1.84M | 1.92M | 1.90M | 2.07M | 2.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.54M | 4.43M | 4.16M | 4.00M | 4.14M |
| Operating Income | -2.18M | -1.75M | -1.48M | -1.96M | -2.25M |
| Income Before Tax | -2.88M | -2.41M | -2.12M | -2.47M | -2.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.88 | -2.41 | -2.12 | -2.47 | -2.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.88M | -2.41M | -2.12M | -2.47M | -2.69M |
| EBIT | -2.18M | -1.75M | -1.48M | -1.96M | -2.25M |
| EBITDA | -1.94M | -1.47M | -1.18M | -1.63M | -1.89M |
| EPS Basic | -0.04 | -0.04 | -0.03 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.04 | -0.04 | -0.03 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 271.42M | 259.58M | 262.51M | 262.46M | 258.29M |
| Average Diluted Shares Outstanding | 271.42M | 259.58M | 262.51M | 262.46M | 258.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |